Meta-analysis of associating liver partition with portal vein ligation and portal vein occlusion for two-stage hepatectomy

British Journal of Surgery

Volumn 103, Issue 13, 2016, Pages 1768-1782

  Eshmuminov, D ^a   Raptis, D A ^a   Linecker, M ^a   Wirsching, A ^a   Lesurtel, M ^a,b   Clavien, P A ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b CROIX ROUSSE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL EMBOLIZATION; FEASIBILITY STUDY; HUMAN; LIGATION; LIVER RESECTION; META ANALYSIS; PATIENT SAFETY; PORTAL VEIN; PROCEDURES; SPECIMEN HANDLING; SURGERY;

EMBOLIZATION, THERAPEUTIC; FEASIBILITY STUDIES; HEPATECTOMY; HUMANS; LIGATION; PATIENT SAFETY; PORTAL VEIN; SPECIMEN HANDLING;

EID: 84987918346     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.10290     Document Type: Review

References (127)

1. Clavien PA, Petrowsky H, DeOliveira ML, Graf R. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med 2007; 356: 1545–1559.
2. Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H. Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg 2000; 232: 777–785.
3. Rahbari NN, Garden OJ, Padbury R, Brooke-Smith M, Crawford M, Adam R et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 2011; 149: 713–724.
4. Honjo I, Suzuki T, Ozawa K, Takasan H, Kitamura O. Ligation of a branch of the portal vein for carcinoma of the liver. Am J Surg 1975; 130: 296–302.
5. Kinoshita H, Sakai K, Hirohashi K, Igawa S, Yamasaki O, Kubo S. Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg 1986; 10: 803–808.
6. Schnitzbauer AA, Lang SA, Goessmann H, Nadalin S, Baumgart J, Farkas SA et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg 2012; 255: 405–414.
7. van Gulik TM, van den Esschert JW. James Cantlie's early messages for hepatic surgeons: how the concept of pre-operative portal vein occlusion was defined. HPB (Oxford) 2010; 12: 81–83.
8. Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunven P et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 1990; 107: 521–527.
9. Aussilhou B, Lesurtel M, Sauvanet A, Farges O, Dokmak S, Goasguen N et al. Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant. J Gastrointest Surg 2008; 12: 297–303.
10. Robles R, Marin C, Lopez-Conesa A, Capel A, Perez-Flores D, Parrilla P. Comparative study of right portal vein ligation versus embolisation for induction of hypertrophy in two-stage hepatectomy for multiple bilateral colorectal liver metastases. Eur J Surg Oncol 2012; 38: 586–593.
11. van Lienden KP, Hoekstra LT, Bennink RJ, van Gulik TM. Intrahepatic left to right portoportal venous collateral vascular formation in patients undergoing right portal vein ligation. Cardiovasc Intervent Radiol 2013; 36: 1572–1579.
12. Broering DC, Hillert C, Krupski G, Fischer L, Mueller L, Achilles EG et al. Portal vein embolization versus portal vein ligation for induction of hypertrophy of the future liver remnant. J Gastrointest Surg 2002; 6: 905–913.
13. Capussotti L, Muratore A, Baracchi F, Lelong B, Ferrero A, Regge D et al. Portal vein ligation as an efficient method of increasing the future liver remnant volume in the surgical treatment of colorectal metastases. Arch Surg 2008; 143: 978–982.
14. Schadde E, Raptis DA, Schnitzbauer AA, Ardiles V, Tschuor C, Lesurtel M et al. Prediction of mortality after ALPPS stage-1: an analysis of 320 patients from the international ALPPS Registry. Ann Surg 2015; 262: 780–785.
15. Schadde E, Schnitzbauer AA, Tschuor C, Raptis DA, Bechstein WO, Clavien PA. Systematic review and meta-analysis of feasibility, safety, and efficacy of a novel procedure: associating liver partition and portal vein ligation for staged hepatectomy. Ann Surg Oncol 2015; 22: 3109–3120.
16. Shindoh J, Vauthey JN, Zimmitti G, Curley SA, Huang SY, Mahvash A et al. Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach. J Am Coll Surg 2013; 217: 126–133.
17. Hwang S, Lee SG, Ko GY, Kim BS, Sung KB, Kim MH et al. Sequential preoperative ipsilateral hepatic vein embolization after portal vein embolization to induce further liver regeneration in patients with hepatobiliary malignancy. Ann Surg 2009; 249: 608–616.
18. Denecke T, Seehofer D, Steffen IG, Grieser C, Stelter L, Schnapauff D et al. Arterial versus portal venous embolization for induction of hepatic hypertrophy before extended right hemihepatectomy in hilar cholangiocarcinomas: a prospective randomized study. J Vasc Interv Radiol 2011; 22: 1254–1262.
19. Pandanaboyana S, Bell R, Hidalgo E, Toogood G, Prasad KR, Bartlett A et al. A systematic review and meta-analysis of portal vein ligation versus portal vein embolization for elective liver resection. Surgery 2015; 157: 690–698.
20. Sun Z, Tang W, Sakamoto Y, Hasegawa K, Kokudo N. A systematic review and meta-analysis of feasibility, safety and efficacy of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) versus two-stage hepatectomy (TSH). Biosci Trends 2015; 9: 284–288.
21. Oxford Centre for Evidence-based Medicine. Oxford Centre for Evidence-based Medicine – Levels of Evidence (March 2009). http://www.cebm.net/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/ [accessed 15 August 2014].
22. The Ottawa Hospital. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp [accessed 15 August 2014].
23. Vauthey JN, Chaoui A, Do KA, Bilimoria MM, Fenstermacher MJ, Charnsangavej C et al. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 2000; 127: 512–519.
24. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205–213.
25. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005; 5: 13.
26. Yoo H, Ko GY, Gwon DI, Kim JH, Yoon HK, Sung KB et al. Preoperative portal vein embolization using an Amplatzer vascular plug. Eur Radiol 2009; 19: 1054–1061.
27. 99mTc-GSA SPECT scintigraphy. Surgery 2003; 133: 495–506.
28. Ko GY, Sung KB, Yoon HK, Kim JH, Weon YC, Song HY. Preoperative portal vein embolization with a new liquid embolic agent. Radiology 2003; 227: 407–413.
29. Vyas S, Bent C, Partelli S, Abraham AT, Hutchins RR, Bhattacharya S et al. Portal vein embolisation for extended hepatectomy: single-centre experience. J Gastrointest Cancer 2012; 43: 413–419.
30. Associating Liver Partition and Portal vein Ligation for Staged hepatectomy (ALPPS). http://www.alpps.net/ [accessed 18 January 2015].
31. Mueller L, Hillert C, Möller L, Krupski-Berdien G, Rogiers X, Broering DC. Major hepatectomy for colorectal metastases: is preoperative portal occlusion an oncological risk factor? Ann Surg Oncol 2008; 15: 1908–1917.
32. Iida H, Aihara T, Ikuta S, Yoshie H, Yamanaka N. Comparison of percutaneous transhepatic portal vein embolization and unilateral portal vein ligation. World J Gastroenterol 2012; 18: 2371–2376.
33. Stavrou GA, Donati M, Ringe KI, Peitgen HO, Oldhafer KJ. Liver remnant hypertrophy induction – how often do we really use it in the time of computer assisted surgery? Adv Med Sci 2012; 57: 251–258.
34. Knoefel WT, Gabor I, Rehders A, Alexander A, Krausch M, Schulte am Esch J et al. In situ liver transection with portal vein ligation for rapid growth of the future liver remnant in two-stage liver resection. Br J Surg 2013; 100: 388–394.
35. am Esch JS, Schmelzle M, Fürst G, Robson SC, Krieg A, Duhme C et al. Infusion of CD133+ bone marrow-derived stem cells after selective portal vein embolization enhances functional hepatic reserves after extended right hepatectomy: a retrospective single-center study. Ann Surg 2012; 255: 79–85.
36. Ardito F, Vellone M, Barbaro B, Grande G, Clemente G, Giovannini I et al. Right and extended-right hepatectomies for unilobar colorectal metastases: impact of portal vein embolization on long-term outcome and liver recurrence. Surgery 2013; 153: 801–810.
37. Barbaro B, Caputo F, Tebala C, Di Stasi C, Vellone M, Giuliante F et al. Preoperative right portal vein embolisation: indications and results. Radiol Med 2009; 114: 553–570.
38. Bellemann N, Stampfl U, Sommer CM, Kauczor HU, Schemmer P, Radeleff BA. Portal vein embolization using a Histoacryl/Lipiodol mixture before right liver resection. Dig Surg 2012; 29: 236–242.
39. Bent CL, Low D, Matson MB, Renfrew I, Fotheringham T. Portal vein embolization using a nitinol plug (Amplatzer vascular plug) in combination with Histoacryl glue and iodinized oil: adequate hypertrophy with a reduced risk of nontarget embolization. Cardiovasc Intervent Radiol 2009; 32: 471–477.
40. Cazejust J, Bessoud B, Le Bail M, Menu Y. Preoperative portal vein embolization with a combination of Trisacryl microspheres, Gelfoam and coils. Diagn Interv Imaging 2015; 96: 57–64.
41. Chung SH, Lee MS, Kim KS, Kim SI, Won JY, Lee Do Y et al. Foam sclerotherapy using polidocanol (aethoxysklerol) for preoperative portal vein embolization in 16 patients. Cardiovasc Intervent Radiol 2011; 34: 1236–1243.
42. Cotroneo AR, Innocenti P, Marano G, Legnini M, Iezzi R. Pre-hepatectomy portal vein embolization: single center experience. Eur J Surg Oncol 2009; 35: 71–78.
43. Covey AM, Brown KT, Jarnagin WR, Brody LA, Schwartz L, Tuorto S et al. Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases. Ann Surg 2008; 247: 451–455.
44. de Baere T, Teriitehau C, Deschamps F, Catherine L, Rao P, Hakime A et al. Predictive factors for hypertrophy of the future remnant liver after selective portal vein embolization. Ann Surg Oncol 2010; 17: 2081–2089.
45. de Graaf W, van Lienden KP, van den Esschert JW, Bennink RJ, van Gulik TM. Increase in future remnant liver function after preoperative portal vein embolization. Br J Surg 2011; 98: 825–834.
46. Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, Nagino M. Portal vein embolization before extended hepatectomy for biliary cancer: current technique and review of 494 consecutive embolizations. Dig Surg 2012; 29: 23–29.
47. Fischman AM, Ward TJ, Horn JC, Kim E, Patel RS, Nowakowski FS et al. Portal vein embolization before right hepatectomy or extended right hepatectomy using sodium tetradecyl sulfate foam: technique and initial results. J Vasc Interv Radiol 2014; 25: 1045–1053.
48. Fujii Y, Shimada H, Endo I, Kamiyama M, Kamimukai N, Tanaka K et al. Changes in clinicopathological findings after portal vein embolization. Hepatogastroenterology 2000; 47: 1560–1563.
49. Giraudo G, Greget M, Oussoultzoglou E, Rosso E, Bachellier P, Jaeck D. Preoperative contralateral portal vein embolization before major hepatic resection is a safe and efficient procedure: a large single institution experience. Surgery 2008; 143: 476–482.
50. Grandadam S, Compagnon P, Arnaud A, Olivie D, Malledant Y, Meunier B et al. Role of preoperative optimization of the liver for resection in patients with hilar cholangiocarcinoma type III. Ann Surg Oncol 2010; 17: 3155–3161.
51. Guiu B, Bize P, Gunthern D, Demartines N, Halkic N, Denys A. Portal vein embolization before right hepatectomy: improved results using n-butyl-cyanoacrylate compared to microparticles plus coils. Cardiovasc Intervent Radiol 2013; 36: 1306–1312.
52. Hemming AW, Reed AI, Howard RJ, Fujita S, Hochwald SN, Caridi JG et al. Preoperative portal vein embolization for extended hepatectomy. Ann Surg 2003; 237: 686–691.
53. 99mTc-GSA SPECT scintigraphy. Surgery 2003; 133: 495–506.
54. Homayounfar K, Liersch T, Schuetze G, Niessner M, Goralczyk A, Meller J et al. Two-stage hepatectomy (R0) with portal vein ligation – towards curing patients with extended bilobular colorectal liver metastases. Int J Colorectal Dis 2009; 24: 409–418.
55. Hong YK, Choi SB, Lee KH, Park SW, Park YN, Choi JS et al. The efficacy of portal vein embolization prior to right extended hemihepatectomy for hilar cholangiocellular carcinoma: a retrospective cohort study. Eur J Surg Oncol 2011; 37: 237–244.
56. Huang SY, Aloia TA, Shindoh J, Ensor J, Shaw CM, Loyer EM et al. Efficacy and safety of portal vein embolization for two-stage hepatectomy in patients with colorectal liver metastasis. J Vasc Interv Radiol 2014; 25: 608–617.
57. Imamura H, Shimada R, Kubota M, Matsuyama Y, Nakayama A, Miyagawa S et al. Preoperative portal vein embolization: an audit of 84 patients. Hepatology 1999; 29: 1099–1105.
58. Kakizawa H, Toyota N, Arihiro K, Naito A, Fujimura Y, Hieda M et al. Preoperative portal vein embolization with a mixture of gelatin sponge and iodized oil: efficacy and safety. Acta Radiol 2006; 47: 1022–1028.
59. ® vascular plugs (AVP): a review of 17 cases.] J Radiol 2011; 92: 899–908.
60. Kang MJ, Jang JY, Kwon W, Park JW, Chang YR, Kim SW. Does preoperative portal vein embolization have any impact on the outcome of right-side hepatectomy for Klatskin tumor? J Gastrointest Surg 2013; 17: 1592–1599.
61. Kasai Y, Hatano E, Iguchi K, Seo S, Taura K, Yasuchika K et al. Prediction of the remnant liver hypertrophy ratio after preoperative portal vein embolization. Eur Surg Res 2013; 51: 129–137.
62. Kim GC, Bae JH, Ryeom HK. Percutaneous preoperative portal vein embolization using a combination of gelatin sponge and Histoacryl glue. Acta Radiol 2009; 50: 1119–1125.
63. Kotenko OG, Furkalo SN, Kondratiuk VA, Fedorov DA. [A portal vein branch embolization as a method of preparation for liver resection.] Klin Khir 2011; (10): 5–9.
64. Kuo SC, Azimi-Tabrizi A, Briggs G, Maher R, Harrington T, Samra JS et al. Portal vein embolization prior to major liver resection. ANZ J Surg 2014; 84: 341–345.
65. Ladurner R, Brandacher G, Riedl-Huter C, Steurer W, Spechtenhauser B, Waldenberger P et al. Percutaneous portal vein embolisation in preparation for extended hepatic resection of primary nonresectable liver tumours. Dig Liver Dis 2003; 35: 716–721.
66. Lee KC, Kinoshita H, Hirohashi K, Kubo S, Iwasa R. Extension of surgical indications for hepatocellular carcinoma by portal vein embolization. World J Surg 1993; 17: 109–115.
67. Libicher M, Herbrik M, Stippel D, Poggenborg J, Bovenschulte H, Schwabe H. [Portal vein embolization using the Amplatzer vascular plug II: preliminary results.] Rofo 2010; 182: 501–506.
68. Lindnér P, Cahlin C, Friman S, Hafstrom L, Klingenstierna H, Lonn L et al. Extended right-sided liver resection for colorectal liver metastases – impact of percutaneous portal venous embolisation. Eur J Surg Oncol 2006; 32: 292–296.
69. Liska V, Treska V, Mirka H, Novák M, Slauf F, Skalicky T et al. [Portal vein embolization – increased chance for liver resecability for malignancies.] Rozhl Chir 2007; 86: 97–101.
70. Lygidakis NJ, Singh G, Bardaxoglou E, Dedemadi G, Sgourakis G, Nestoridis J et al. Two-stage liver surgery for advanced liver metastasis synchronous with colorectal tumor. Hepatogastroenterology 2004; 51: 413–418.
71. Mailey B, Truong C, Artinyan A, Khalili J, Sanchez-Luege N, Denitz J et al. Surgical resection of primary and metastatic hepatic malignancies following portal vein embolization. J Surg Oncol 2009; 100: 184–190.
72. Massimino KP, Kolbeck KJ, Enestvedt CK, Orloff S, Billingsley KG. Safety and efficacy of preoperative right portal vein embolization in patients at risk for postoperative liver failure following major right hepatectomy. HPB (Oxford) 2012; 14: 14–19.
73. Mathisen O, Dorenberg E, Edwin B, Gladhaug I, Hafsahl G, Rokke O. [Portal vein embolization before surgery for liver tumours.] Tidsskr Nor Laegeforen 2009; 129: 29–32.
74. Mihara K, Sugiura T, Okamura Y, Kanemoto H, Mizuno T, Moriguchi M et al. A predictive factor of insufficient liver regeneration after preoperative portal vein embolization. Eur Surg Res 2013; 51: 118–128.
75. Nadalin S, Capobianco I, Li J, Girotti P, Konigsrainer I, Konigsrainer A. Indications and limits for associating liver partition and portal vein ligation for staged hepatectomy (ALPPS). Lessons learned from 15 cases at a single centre. Z Gastroenterol 2014; 52: 35–42.
76. Nafidi O, Désy D, Létourneau R, Côté J, Plasse M, Vandenbroucke F et al. Hypertrophy of the non-embolized liver after chemotherapy. HPB (Oxford) 2009; 11: 103–107.
77. Nanashima A, Sumida Y, Abo T, Nonaka T, Takeshita H, Hidaka S et al. Clinical significance of portal vein embolization before right hepatectomy. Hepatogastroenterology 2009; 56: 773–777.
78. Okabe H, Beppu T, Nakagawa S, Yoshida M, Hayashi H, Masuda T et al. Percentage of future liver remnant volume before portal vein embolization influences the degree of liver regeneration after hepatectomy. J Gastrointest Surg 2013; 17: 1447–1451.
79. Pamecha V, Glantzounis G, Davies N, Fusai G, Sharma D, Davidson B. Long-term survival and disease recurrence following portal vein embolisation prior to major hepatectomy for colorectal metastases. Ann Surg Oncol 2009; 16: 1202–1207.
80. Peregrin JH, Kautznerová D, Honsová E, Oliverius M, Köcher M, Černá M et al. Portal vein embolization prior extended right hepatectomy using poly2-hydroxyethylmethacrylate. Ces Radiol 2014; 68: 113–119.
81. Peynircioglu B, Cil B, Ozkan F, Koc O, Akinci D, Abbasoglu O et al. Portal vein embolization with different embolic agents for right hepatectomy. Turk J Gastroenterol 2012; 23: 148–155.
82. Polishchuk LO, Skipenko OG, Abdullaev AG, Poliakov RS, Sekacheva MI, Shatverian GA et al. [The colorectal cancer progression after the right branch of vena porta occlusion.] Khirurgiia (Mosk) 2011; (10): 4–12.
83. Popescu I, David L, Brasoveanu V, Boros M, Hrehoret D. Two-stage hepatectomy: an analysis of a single center's experience. Magy Seb 2006; 59: 184–189.
84. Radeleff B, Schawo S, Hoffmann K, Schemmer P, Noeldge G, Kauffmann GW et al. Efficacy and safety of percutaneous transhepatic portal embolization before right liver resection using an Ethibloc/Lipiodol mixture: a single-center experience. Digest Surg 2008; 25: 52–59.
85. Ratti F, Cipriani F, Ferla F, Catena M, Paganelli M, Aldrighetti LA. Hilar cholangiocarcinoma: preoperative liver optimization with multidisciplinary approach. Toward a better outcome. World J Surg 2013; 37: 1388–1396.
86. Regimbeau JM, Fuks D, Le Treut YP, Bachellier P, Belghiti J, Boudjema K et al.; AFC-HC study group. Surgery for hilar cholangiocarcinoma: a multi-institutional update on practice and outcome by the AFC-HC study group. J Gastrointest Surg 2011; 15: 480–488.
87. Sakamoto Y, Shimada K, Nara S, Esaki M, Kajiwara T, Arai Y et al. Risk factors for early bilirubinemia after major hepatectomy for perihilar cholangiocarcinoma with portal vein embolization. Hepatogastroenterology 2010; 57: 22–28.
88. Sakuhara Y, Abo D, Hasegawa Y, Shimizu T, Kamiyama T, Hirano S et al. Preoperative percutaneous transhepatic portal vein embolization with ethanol injection. AJR Am J Roentgenol 2012; 198: 914–922.
89. Shah A, Goffette P, Hubert C, Lerut J, Van Beers BB, Annet L et al. Comparison of different methods to quantify future liver remnants after preoperative portal vein embolization to predict postoperative liver failure. Hepatogastroenterology 2011; 58: 109–114.
90. Shimura T, Suehiro T, Suzuki H, Okada K, Araki K, Kuwano H. Trans-ileocecal portal vein embolization as a preoperative treatment for right trisegmentectomy with caudate lobectomy. J Surg Oncol 2007; 96: 438–441.
91. Shin JH, Yoon HK, Kwon J, Lee SW, Chae EY, Ko GY et al. Volumetric analysis of the liver after right portal vein embolization: mid-term follow-up based on embolization score. Clin Radiol 2010; 65: 288–296.
92. Simoneau E, Aljiffry M, Salman A, Abualhassan N, Cabrera T, Valenti D et al. Portal vein embolization stimulates tumour growth in patients with colorectal cancer liver metastases. HPB (Oxford) 2012; 14: 461–468.
93. Sirichindakul B, Nonthasoot B, Taesombat W, Supaphol J, Nivatvongs S, Janchai A et al. Role of portal vein embolization in hepatobiliary malignancy. Hepatogastroenterology 2007; 54: 2297–2300.
94. Srisud W, Pinjaroen N, Tanpouwpong N, Saksirinukul T. Percutaneous ipsilateral portal vein embolization using Histoacryl glue: changing LR, resectibility rate and complications. Asian Biomedicine 2012; 6: 361–367.
95. Sturesson C, Keussen I, Tranberg KG. Prolonged chemotherapy impairs liver regeneration after portal vein occlusion – an audit of 26 patients. Eur J Surg Oncol 2010; 36: 358–364.
96. Sugawara Y, Yamamoto J, Higashi H, Yamasaki S, Shimada K, Kosuge T et al. Preoperative portal embolization in patients with hepatocellular carcinoma. World J Surg 2002; 26: 105–110.
97. Szijártó A, Hargitai B, Fischer S, Darvas K, Kupcsulik P. Two-staged procedure of portal ligation and hepatectomy monitored by ICG clearance. J Invest Surg 2009; 22: 63–68.
98. Tanaka K, Shimada H, Matsuo K, Ueda M, Endo I, Togo S. Remnant liver regeneration after two-stage hepatectomy for multiple bilobar colorectal metastases. Eur J Surg Oncol 2007; 33: 329–335.
99. Tarazov PG, Granov DA, Sergeev VI, Polikarpov AA, Polysalov VN, Rozengauz EV. Preoperative portal vein embolization for liver malignancies. Hepatogastroenterology 2006; 53: 566–570.
100. Treska V, Skalicky T, Sutnar A, Vaclav L, Fichtl J, Kinkorova J et al. Prognostic importance of some clinical and therapeutic factors for the effect of portal vein embolization in patients with primarily inoperable colorectal liver metastases. Arch Med Sci 2013; 9: 47–54.
101. Tsim N, Healey AJ, Frampton AE, Habib NA, Bansi DS, Wasan H et al. Two-stage resection for bilobar colorectal liver metastases: R0 resection is the key. Eur J Surg Oncol 2011; 18: 1939–1946.
102. Tsuda M, Kurihara N, Saito H, Yamaki T, Shimamura H, Narushima Y et al. Ipsilateral percutaneous transhepatic portal vein embolization with gelatin sponge particles and coils in preparation for extended right hepatectomy for hilar cholangiocarcinoma. J Vasc Interv Radiol 2006; 17: 989–994.
103. Turrini O, Ewald J, Viret F, Sarran A, Goncalves A, Delpero JR. Two-stage hepatectomy: who will not jump over the second hurdle? Eur J Surg Oncol 2012; 38: 266–273.
104. Wakabayashi H, Ishimura K, Okano K, Karasawa Y, Goda F, Maeba T et al. Application of preoperative portal vein embolization before major hepatic resection in patients with normal or abnormal liver parenchyma. Surgery 2002; 131: 26–33.
105. Wicherts DA, de Haas RJ, Andreani P, Sotirov D, Salloum C, Castaing D et al. Impact of portal vein embolization on long-term survival of patients with primarily unresectable colorectal liver metastases. Br J Surg 2010; 97: 240–250.
106. Yamashita S, Hasegawa K, Takahashi M, Inoue Y, Sakamoto Y, Aoki T et al. One-stage hepatectomy following portal vein embolization for colorectal liver metastasis. World J Surg 2013; 37: 622–628.
107. Yi B, Xu AM, Lai EC, Qu ZQ, Cheng QB, Liu C et al. Preoperative portal vein embolization for hilar cholangiocarcinoma – a comparative study. Hepatogastroenterology 2010; 57: 1341–1346.
108. Zboril P, Vyslouzil K, Klementa I, Skalicky P, Vomackova K, Cerna M et al. The significance of portal vein embolization in the treatment of colorectal liver metastases. Neoplasma 2012; 59: 175–182.
109. Omary RA, Bettmann MA, Cardella JF, Bakal CW, Schwartzberg MS, Sacks D et al; Society of Interventional Radiology Standards of Practice Comittee. Quality improvement guidelines for the reporting and archiving of interventional radiology procedures. J Vasc Interv Radiol 2003; 14: S293–S295.
110. National Cancer Institute. Common Terminlogy Criteria for Adverse Events. http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm [accessed 5 August 2016].
111. Wilms C, Mueller L, Lenk C, Wittkugel O, Helmke K, Krupski-Berdien G et al. Comparative study of portal vein embolization versus portal vein ligation for induction of hypertrophy of the future liver remnant using a mini-pig model. Ann Surg 2008; 247: 825–834.
112. Robles R, Parrilla P, Lopez-Conesa A, Brusadin R, de la Pena J, Fuster M et al. Tourniquet modification of the associating liver partition and portal ligation for staged hepatectomy procedure. Br J Surg 2014; 101: 1129–1134.
113. Schlegel A, Lesurtel M, Melloul E, Limani P, Tschuor C, Graf R et al. ALPPS: from human to mice highlighting accelerated and novel mechanisms of liver regeneration. Ann Surg 2014; 260: 839–846.
114. Wu Y, Campbell KA, Sitzmann JV. Hormonal and splanchnic hemodynamic alterations following hepatic resection. J Surg Res 1993; 55: 44–48.
115. Thasler WE, Bein T, Jauch KW. Perioperative effects of hepatic resection surgery on hemodynamics, pulmonary fluid balance, and indocyanine green clearance. Langenbecks Arch Surg 2002; 387: 271–275.
116. Shteyer E, Liao Y, Muglia LJ, Hruz PW, Rudnick DA. Disruption of hepatic adipogenesis is associated with impaired liver regeneration in mice. Hepatology 2004; 40: 1322–1332.
117. Jara M, Bednarsch J, Valle E, Lock JF, Malinowski M, Schulz A et al. Reliable assessment of liver function using LiMAx. J Surg Res 2015; 193: 184–189.
118. de Graaf W, van Lienden KP, Dinant S, Roelofs JJ, Busch OR, Gouma DJ et al. Assessment of future remnant liver function using hepatobiliary scintigraphy in patients undergoing major liver resection. J Gastrointest Surg 2010; 14: 369–378.
119. Hoekstra LT, de Graaf W, Nibourg GA, Heger M, Bennink RJ, Stieger B et al. Physiological and biochemical basis of clinical liver function tests: a review. Ann Surg 2013; 257: 27–36.
120. Shindoh J, Tzeng CW, Aloia TA, Curley SA, Huang SY, Mahvash A et al. Safety and efficacy of portal vein embolization before planned major or extended hepatectomy: an institutional experience of 358 patients. J Gastrointest Surg 2014; 18: 45–51.
121. Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK et al. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg 2004; 240: 698–708.
122. Lehmann K, Eshmuminov D, Slankamenac K, Kranzbühler B, Clavien PA, Vonlanthen R et al. Where oncologic and surgical complication scoring systems collide: time for a new consensus for CRS/HIPEC. World J Surg 2016; 40: 1075–1081.
123. Clavien PA. Targeting quality in surgery. Ann Surg 2013; 258: 659–668.
124. Clavien PA, Puhan MA. Biased reporting in surgery. Br J Surg 2014; 101: 591–592.
125. Li J, Ewald F, Kantas A, Achilles E, Fischer L, Nashan B. Learning curve effect in ALPPS – a retrospect analysis of four years' experience. HPB (Oxford) 2016; 18(Suppl 2): e735.
126. Oldhafer KJ, Stavrou GA, van Gulik TM; Core Group. ALPPS – Where do we stand, where do we go?: eight recommendations from the first international expert meeting. Ann Surg 2016; 263: 839–841.
127. Clavien PA, Lillemoe KD. Associating liver partition and portal vein ligation for staged hepatectomy. Ann Surg 2016; 263: 835–836.